Nautilus Biotechnology published a Nature Methods paper on proteoform analysis and tau proteoform analysis.
Published
Signal category
Research & Knowledge
Quote
“check out this excellent ”
— Nautilus Biotechnology team
Company
Nautilus Biotechnology
Delivering on the Promise of the Human Proteome
- Industry
- Biotechnology Research
- Location
- San Carlos, US
- Company size
- 151 employees
Born from the founders’ recognition that their diverse but complementary skills and experiences would enable them to successfully address challenges that others had not, Nautilus (Nasdaq: NAUT) set about solving a vexing problem: how to bring true proteomics to the world in a way that accelerates therapeutic development, dramatically improves medical diagnostics, and makes personalized and predictive medicine a reality. The extraordinary team at Nautilus represents a wide spectrum of disciplines and expertise, including: protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, bioinformaticists, software engineers, and more. Nautilus is positioned to revolutionize proteomics, transform the way drugs are developed, and significantly improve the way human health is managed.
Founded 2016